Hematology Oncology Associates of Central New York-Rome — Rome, New York

Hematology Oncology Associates of Central New York-Rome is a clinical research site located in Rome, New York, United States 13440.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Hematology Oncology Associates of Central New York-Rome has participated in 10 clinical trials with 5 currently active.

Therapeutic areas: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.

Sponsors: SWOG Cancer Research Network, Eastern Cooperative Oncology Group, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology Associates of Central New York-Rome?

Hematology Oncology Associates of Central New York-Rome has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology Associates of Central New York-Rome conducted?

Hematology Oncology Associates of Central New York-Rome has 10 clinical trials on record, with 5 currently active. Their work covers brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.

Is Hematology Oncology Associates of Central New York-Rome accredited by Crixeo Health?

Yes — Hematology Oncology Associates of Central New York-Rome holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Hematology Oncology Associates of Central New York-Rome?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.